Digest Réseau Comment ça marche
Réseau
/
Sociétés
Te
Non vérifié

Teva Pharmaceutical Industries Ltd

Ce que nous écrivons

Annonces ÉconomiquesFinanceIndustrie pharmaceutiqueManagement/Organisation d'EntrepriseMédecine Santé Bien-être

53 communiqués de presse

Voir tous les communiqués de presse
30/05/2025
Industrie pharmaceutique
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1,00
0
30/05/2025
Industrie pharmaceutique
Médecine Santé Bien-être
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to Date
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1,00
0
29/05/2025
Industrie pharmaceutique
Médecine Santé Bien-être
Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1,00
0
27/05/2025
Industrie pharmaceutique
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1,00
0
27/05/2025
Industrie pharmaceutique
Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1,00
0
27/05/2025
Industrie pharmaceutique
Médecine Santé Bien-être
Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1,00
0
22/05/2025
Industrie pharmaceutique
Finance
Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1,00
0
20/05/2025
Industrie pharmaceutique
Finance
Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1,00
0
20/05/2025
Industrie pharmaceutique
Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1,00
0
19/05/2025
Industrie pharmaceutique
Finance
Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031
Source
Teva Pharmaceutical Industries Ltd
Émetteur
GLOBENEWSWIRE
1,00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0